APA (7th ed.) Citation

Alam, T., Ahmed, D., Ahmed, T., Chisti, M. J., Rahman, M. W., Asthana, A. K., . . . Simon, J. (2020). A double-blind placebo-controlled trial of azithromycin to reduce mortality and improve growth in high-risk young children with non-bloody diarrhoea in low resource settings: The Antibiotics for Children with Diarrhoea (ABCD) trial protocol. Current controlled trials in cardiovascular medicine, 21(1), 71-10. https://doi.org/10.1186/s13063-019-3829-y

Chicago Style (17th ed.) Citation

Alam, T., et al. "A Double-blind Placebo-controlled Trial of Azithromycin to Reduce Mortality and Improve Growth in High-risk Young Children with Non-bloody Diarrhoea in Low Resource Settings: The Antibiotics for Children with Diarrhoea (ABCD) Trial Protocol." Current Controlled Trials in Cardiovascular Medicine 21, no. 1 (2020): 71-10. https://doi.org/10.1186/s13063-019-3829-y.

MLA (9th ed.) Citation

Alam, T., et al. "A Double-blind Placebo-controlled Trial of Azithromycin to Reduce Mortality and Improve Growth in High-risk Young Children with Non-bloody Diarrhoea in Low Resource Settings: The Antibiotics for Children with Diarrhoea (ABCD) Trial Protocol." Current Controlled Trials in Cardiovascular Medicine, vol. 21, no. 1, 2020, pp. 71-10, https://doi.org/10.1186/s13063-019-3829-y.